N

NeuroX1 Inc.

7 employees

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Artificial Intelligence
cancer
Life Science
Biopharma
biotechnology
AI
generativeAI
neurodegenerative
Parkinson's
Alzheimer's
Neuroscience
neurology
neuroscience
brain
generative drug discovery
pediatric rare disease
Machine Learning
rare disease

Date founded

2021

Funding rounds raised

Total raised

$1.3M

from 2 investors over 2 rounds

N

NeuroX1 Inc. raised $500K on March 3, 2023

Investors: Drive Capital

N

NeuroX1 Inc. raised $1.3M on December 31, 2021

Investors: Vibe Capital

FAQ